Saturday, October 10, 2026
ExploreSearch
Via News
MarketIndexes

NASDAQ 100 Jumps By 13% In The Last 21 Sessions

ViaNews Editorial Team

November 28, 2023

NASDAQ 100 Jumps By 13% In The Last 21 Sessions

(VIANEWS) - NASDAQ 100 (NDX) has been up by 13.27% for the last 21 sessions. At 19:11 EST on Monday, 27 November, NASDAQ 100 (NDX) is $15,981.63.

Volume

Today's last reported volume for NASDAQ 100 is 132116508, 94.98% below its average volume of 2636465892.75.

About NASDAQ 100's yearly highs and lows, it's 49.76% up from its 52-week low and 0.85% down from its 52-week high.

Volatility

NASDAQ 100's last week, last month's, and last quarter's current intraday variation average was a negative 0.09%, a positive 0.63%, and a positive 0.87%, respectively.

NASDAQ 100's highest amplitude of average volatility was 0.38% (last week), 0.83% (last month), and 0.87% (last quarter), respectively.

More news about NASDAQ 100 (NDX).

Categories

MarketIndexes

Tags

IndexWorld IndicesIndicesNDXNASDAQ 100Price UpINDICES Price UpIndex Now
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic Enterprise Software Consolidates: Big Platforms Push Autonomy While Startups Get Absorbed
Enterprise software is shifting toward autonomous, AI-agent-driven products. SAP (Autonomous Enterprise, Joule), Meta (a new Enterprise Platform led by ex-MongoDB CEO Chirantan Desai) and UiPath (raised guidance) are pushing from the top. Meanwhile AI-security and governance startups are being acquired (Fortinet–Virtue AI, Harvey–Guardrails AI, Tiny–Oso Cloud) and seed-stage agent companies keep raising capital (Dextr, Latitude, Groq). Investors such as Norwest's Sean Jacobsohn see finance and ERP back-office software as the easier area to disrupt. Trust and enforced governance are treated as preconditions for regulated sectors like finance, and AI is judged unreliable for calculations.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,366 source documents archived
Query this data → isubstrate.com